
Academic collaboration to develop therapies for genetic diseases and cancers
BridgeBio has collaborated with two new academic institutions, Columbia University and Mount Sinai (Icahn Mount Sinai), to translate research discoveries into potential therapies for patients with genetic diseases and genetically driven cancers. “Columbia University and Mount Sinai are known for bringing together some of the most talented scientists… Read More















